Company Profile: 23andMe
Summary
23andMe is a personal genomics and biotechnology company that leverages machine learning technology to provide DNA analysis services. It also offers web-based interactive tools to individuals, helping them understand their own genetics information.
Scope
The report provides information and insights into 23andMe, including -
- Overview of the company and its product offering
- Detailed insight into its business operation, technology, revenue model, geographical presence and business model
- Information on partnerships, funding and awards it received
- Biography of top management.
Reasons to buy
- Gain insights into 23andMes business operations.
- Gain insights into funding and partnerships.
- Gain understanding about its technology focus and success factors.
Company Overview
Technology Focus
Product Overview
Partnerships & Funding
Key Employees
Appendix
The Public Safety LTE & 5G Market: 2023 – 2030 – Opportunities, Challenges, Strategies & Forecasts
With the commercial availability of 3GPP-standards compliant MCX (Mission-Critical PTT, Video & Data), HPUE (High-Power User Equipment), IOPS (Isolated Operation for Public Safety) and other critical communications features, LTE and
USD 2500 View ReportLTE & 5G for Critical Communications: 2023 – 2030 – Opportunities, Challenges, Strategies & Forecasts
For nearly a century, the critical communications industry has relied on narrowband LMR (Land Mobile Radio) networks for mission-critical voice and low-speed data services. Over time, these systems have evolved
USD 3500 View ReportU.S Infectious Disease Testing Market Shares
2024 U.S. Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players This new report provides infectious diseases testing market shares.The report analyses current and emerging suppliers of
USD 950 View ReportU.S Infectious Disease Testing Market Shares
2024 U.S. Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players This new report provides infectious diseases testing market shares.The report analyses current and emerging suppliers of
USD 950 View ReportFill The Form For Sample Request